Related Experiment Videos
Nephrotic syndrome in children-a clinical study
Summary
This study analyzed 54 children with Nephrotic Syndrome, finding it more common in boys and peaking at age 3. Early-stage patients without nephritic features responded best to Prednisolone treatment.
Area of Science:
- Pediatric Nephrology
- Clinical Biochemistry
- Pharmacology
Background:
- Nephrotic Syndrome is a significant kidney disorder in children.
- Understanding its clinical and biochemical profiles is crucial for effective management.
- Steroid therapy, particularly Prednisolone, is a cornerstone treatment.
Purpose of the Study:
- To describe the clinical and biochemical characteristics of childhood Nephrotic Syndrome.
- To evaluate the response to Prednisolone therapy in affected children.
- To identify factors associated with treatment success.
Main Methods:
- Retrospective analysis of 54 pediatric patients diagnosed with Nephrotic Syndrome over six years.
- Clinical data collection including age, sex, and presenting features.
- Assessment of treatment response in 43 patients receiving Prednisolone.
Main Results:
- Nephrotic Syndrome was more prevalent in male children.
- The highest incidence occurred in 3-year-old children.
- Patients with recent onset and no nephritic features showed an excellent response to Prednisolone.
Conclusions:
- Prednisolone is an effective treatment for Nephrotic Syndrome, especially in early stages.
- Early diagnosis and treatment without complicating nephritic features improve outcomes.
- Further research into specific pediatric Nephrotic Syndrome subtypes is warranted.